Martin Lindner
Overview
Explore the profile of Martin Lindner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mengler K, Garbade S, Gleich F, Thimm E, May P, Lindner M, et al.
Pediatrics
. 2024 Jul;
154(2.
PMID: 38957900
Objective: Maple syrup urine disease (MSUD), a life-threatening metabolic disorder, is included in newborn screening (NBS) programs worldwide. The study aims to evaluate the impact of NBS on the long-term...
2.
Reischl-Hajiabadi A, Schnabel E, Gleich F, Mengler K, Lindner M, Burgard P, et al.
J Inherit Metab Dis
. 2024 Apr;
47(4):674-689.
PMID: 38563533
The current German newborn screening (NBS) panel includes 13 inherited metabolic diseases (IMDs). In addition, a NBS pilot study in Southwest Germany identifies individuals with propionic acidemia (PA), methylmalonic acidemia...
3.
Mutze U, Ottenberger A, Gleich F, Maier E, Lindner M, Husain R, et al.
Ann Clin Transl Neurol
. 2024 Jan;
11(4):883-898.
PMID: 38263760
Objective: This study aims to elucidate the long-term benefit of newborn screening (NBS) for individuals with long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiency, inherited metabolic diseases included...
4.
Mutze U, Henze L, Schroter J, Gleich F, Lindner M, Grunert S, et al.
J Inherit Metab Dis
. 2023 Jul;
46(6):1063-1077.
PMID: 37429829
Newborn screening (NBS) allows early identification of individuals with rare disease, such as isovaleric aciduria (IVA). Reliable early prediction of disease severity of positively screened individuals with IVA is needed...
5.
Mutze U, Gleich F, Baric I, Baumgartner M, Burlina A, Chapman K, et al.
J Inherit Metab Dis
. 2022 Oct;
46(2):220-231.
PMID: 36266255
The SARS-CoV-2 pandemic challenges healthcare systems worldwide. Within inherited metabolic disorders (IMDs) the vulnerable subgroup of intoxication-type IMDs such as organic acidurias (OA) and urea cycle disorders (UCD) show risk...
6.
Jandt U, Bruelheide H, Jansen F, Bonn A, Grescho V, Klenke R, et al.
Nature
. 2022 Oct;
611(7936):512-518.
PMID: 36261519
Long-term analyses of biodiversity data highlight a 'biodiversity conservation paradox': biological communities show substantial species turnover over the past century, but changes in species richness are marginal. Most studies, however,...
7.
Jandt U, Bruelheide H, Berg C, Bernhardt-Romermann M, Bluml V, Bode F, et al.
Sci Data
. 2022 Oct;
9(1):631.
PMID: 36261458
Vegetation-plot resurvey data are a main source of information on terrestrial biodiversity change, with records reaching back more than one century. Although more and more data from re-sampled plots have...
8.
Boy N, Muhlhausen C, Maier E, Ballhausen D, Baumgartner M, Beblo S, et al.
J Inherit Metab Dis
. 2022 Oct;
46(3):482-519.
PMID: 36221165
Glutaric aciduria type 1 is a rare inherited neurometabolic disorder of lysine metabolism caused by pathogenic gene variations in GCDH (cytogenic location: 19p13.13), resulting in deficiency of mitochondrial glutaryl-CoA dehydrogenase...
9.
Mutze U, Garbade S, Gleich F, Lindner M, Freisinger P, Hennermann J, et al.
J Inherit Metab Dis
. 2022 Sep;
46(1):15-27.
PMID: 36134599
Newborn screening (NBS) for inherited metabolic diseases (IMDs) substantially shortens a patient's journey. It enables the early start of metabolic treatment which might prevent potentially lethal neonatal disease manifestations, while...
10.
Grunert S, Derks T, Adrian K, Al-Thihli K, Ballhausen D, Bidiuk J, et al.
Genet Med
. 2022 May;
24(8):1781-1788.
PMID: 35503103
Purpose: This paper aims to report collective information on safety and efficacy of empagliflozin drug repurposing in individuals with glycogen storage disease type Ib (GSD Ib). Methods: This is an...